Huawei Watch GT 6 Pro Adds Diabetes Risk Screening Feature

Huawei just made the Watch GT 6 Pro the first major smartwatch to include diabetes risk screening. That is a significant step for wearable health tech, and it puts Huawei ahead of Garmin, Apple, and Samsung on this specific feature.

The screening uses optical sensors and algorithm-based risk scoring rather than direct blood glucose measurement. It is a risk flag, not a diagnosis. Think of it like HRV or blood oxygen: a signal worth tracking, not a number to panic over.

Garmin, Apple, and Samsung all hold patents in this space. Current estimates point to 2026-2027 for any commercial release from those brands. Garmin has been quiet about it publicly, but their biosensor R&D suggests glucose monitoring is on the roadmap alongside the health metrics already in the Fenix 8 and Epix Pro lines.

For endurance athletes, this matters more than it sounds. Glucose regulation is directly tied to fueling strategy, recovery, and long-term metabolic health. Ironman athletes and ultra runners who already use tools like Supersapiens CGM patches will understand the value of a passive, always-on risk indicator on their wrist.

Not a replacement for clinical testing. But as a daily awareness tool built into a watch you already wear, it is a smart addition. Worth watching what Garmin and Apple do with it by 2027.